Archive for October, 2009

New York Shipbuilding – Mesothelioma & Asbestos Exposure

Wednesday, October 28th, 2009

Mesothelioma Asbestos Cancer Malignant Pleural Pericardial Peritoneal

Diagnosis of Mesothelioma: Part – 1

Wednesday, October 28th, 2009

Mesothelioma is not always diagnosed because the cancer is still unrecognizable. A mesothelioma diagnosis may often be classified as another condition because the symptoms are similar to those of other illnesses. Mesothelioma’s symptoms are not unique and the disease’s relative rarity, cases of mesothelioma misdiagnosed are not uncommon.

Medical history:

Diagnosis begins with a review of the patient’s medical history. The first step involved in diagnosis is providing a full and accurate medical history to your doctor, including details about current and past health concerns, as well as the types of symptoms and signs signs including shortness of breath, chest pains, swollen abdomen, and more you are currently experiencing.

It is important to mention any possible exposure to asbestos. Without revealing this fact, your doctor may not consider asbestos-related diseases in his or her examination. Mesothelioma patients are typically diagnosed within three to six months of their first visit to a doctor with complaints about breathing problems or chest and abdominal pain.

Levy, Phillips & Konigsberg: Mesothelioma & Qui Tam Attorney

Wednesday, October 14th, 2009

mesothelioma attorney asbestos cancer lawyer medical malpractice personal injury lawsuit new york qui tam

Pathophysiology of Mesothelioma: Part-2

Wednesday, October 14th, 2009

One of the most common carcinogen asbestos develops mesothelioma. Asbestos acts as a carcinogen in the growth of both pleural and peritoneal mesothelioma which occurs in subsiquent stages of triggering and growth. Asbestos fibres are thought to exert their carcinogenic effects via direct physical interactions with the cells of the mesothelium in conjunction with indirect effects following interaction with inflammatory cells such as macrophages.

Asbestos has also been shown to aid the entry of foreign DNA into healthy cells. This foreign DNA can insert itself into the human genome, causing mutations by one of the following mechanisms:

• Activation of oncogenes
• Activation of proto-oncogenes due to incorporation of foreign DNA containing a promoter region
• Prevention of apoptosis
• Inactivation of tumor suppressor genes
• Activation of DNA repair enzymes

Different types of asbestos fibers were studied in rats and mice, showed that long, thin fibres caused a higher incidence of mesothelioma than did short fibres and that cells will actually phagocytose longer fibres more effectively than shorter fibres. Interactive analysis between asbestos fibres and DNA has shown that phagocytosed fibres are able to make contact with chromosomes, often adhering to the chromatin fibres or gets entangled within the chromosome. This direct contact between the asbestos fibre and the chromosomes or structural proteins of the spindle apparatus can induce complex abnormalities. The most common abnormality is monosomy of chromosome 22. Other frequent abnormalities include structural rearrangement of 1p, 3p, 9p and 6q chromosome arms. Common gene abnormalities in pleural and peritoneal mesothelioma cell lines include deletion of the tumor suppressor genes.

Following asbestos phagocytosis, macrophages generate increased amounts of hydroxyl radicals. However, these free radicals are also known clastogenic and membrane-active agents thought to promote asbestos carcinogenicity. These oxidants can participate in the oncogenic process by directly and indirectly interacting with DNA, modifying membrane-associated cellular events, including oncogene activation and perturbation of cellular antioxidant defences. Asbestos also may possess immunosuppressive properties.

Mesothelioma Lawyers

Tuesday, October 13th, 2009

mesothelioma lawyers asbestos attorneys lung cancer

Pathophysiology of Mesothelioma: Part-1

Tuesday, October 13th, 2009

The mesothelium consists of an individual band of bedfast to cuboidal beef basic the epithelial lining of the aqueous cavities of the physique including the peritoneal, pericardial and pleural cavities. Asbestos fibers after inhalation deposited in the parenchyma of lung, results in these fibres penetrating through into the pleural membranes where the fibre can then be carried to the pleural surface, thus leading to the development of malignant mesothelial plaques. Fibres from the lungs being transported to the abdomen and associated organs via the lymphatic system. Peritoneal mesothelioma is developed by this process, it remains unresolved. Additionally, asbestos fibres may be deposited in the gut after ingestion of sputum contaminated with asbestos fibres.

It has been known that when there is contamination of pleural membranes with asbestos or other mineral fibres causes cancer (carcinogenesis). Pleural mesothelioma usually begins as discrete plaques and nodules that coalesce to produce a sheet-like neoplasm. At the lower part of the chest tumor growth usually begins. The tumor may invade the diaphragm and encase the surface of the lung and interlobar fissures. The tumor may also grow along drainage and thoracotomy tracts. As the disease progresses, it often extends into the pulmonary parenchyma, chest wall, and mediastinum. Pleural mesothelioma may extend into the esophagus, ribs, vertebra, brachial plexus, and superior vena cava.

Long thin asbestos fibers (blue asbestos, amphibole fibers) are more potent carcinogens than “feathery fibers” (chrysotile or white asbestos fibers). However, the development of mesothelioma in rats has been demonstrated following intra-pleural inoculation of phosphorylated chrysotile fibres. It has been suggested that in humans, transport of fibres to the pleura is critical to the pathogenesis of mesothelioma.